$HOOD

Robinhood Markets Reports Earnings on Oct. 27. Is It a Better Buy Than Morningstar?

Robinhood reported FY 2025 revenue of $2.4B, up 7.5%, with net income of $374.2M. Morningstar reported a debt-to-equity ratio of 1.2x and free cash flow of $442.6M. Robinhood faces regulatory risks, while Morningstar risks technological and market volatility challenges. Robinhood's valuation is higher due to faster growth and new markets.

Original reporting
Published Oct 14, 2026, 9:31 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 9:49 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Robinhood Markets Reports Earnings on Oct. 27. Is It a Better Buy Than Morningstar? — source image
Decision brief

The 30-second read

$HOODNeutralLow
01

Why it matters

Both companies' stocks are unlikely to move significantly as the data is already priced in.

02

Market read

Recap of earnings with risk commentary; low trading relevance.

03

What to watch

Potential for new product launches or partnership announcements not covered.

Relevance 4/10Novelty 2/10Timing: none

Background

The article compares Robinhood and Morningstar using FY 2025 results that were released months earlier.

Company-level read

Ticker impact

$HOODNeutralMedium confidence
Context

Recaps Robinhood's FY 2025 earnings and regulatory risks; no new data beyond prior release.

Expected impact

potential pressure as market prices in regulatory risk

Evidence & confidence

Earnings already known; only risk commentary adds modest downside bias.

$MORNNeutralMedium confidence
Context

Recaps Morningstar's financial metrics and risk factors; no fresh information.

Expected impact

limited movement, likely flat as data is already public

Evidence & confidence

Article repeats known figures; no new catalyst.

Market effects

Highlights regulatory scrutiny on retail brokerages, may affect sector sentiment.

U.S. market focus; no broader regional effect.

Limited to U.S. investors.

Counterpoint

Despite regulatory risk, Robinhood's growth in subscriptions could support upside.

Key entities

  • Robinhood Markets

    U.S.-listed brokerage platform (HOOD).

  • Morningstar, Inc.

    Financial data and investment research firm (MORN).

Related articles

$HOODMed

Evercore ISI Upgrades Robinhood Markets (HOOD) to Outperform wit

Evercore ISI upgraded Robinhood Markets (HOOD) to Outperform with a $130 price target, citing strong user and deposit growth. HOOD's stock rose 0.32% in pre-market trading to $109.37. The company's P/S ratio is 20x, above historical and industry norms, indicating high growth expectations. Insider selling was significant, while institutional interest was mixed.

$ASTSMed

Bristol-Myers Squibb Slips Despite Fresh Trial Wins

AST Space Mobile (ASTS) and Robinhood (HOOD) saw pre-market gains. ASTS rose 3% after Deutsche Bank upgraded it to Buy with a $93 target. HOOD gained 0.4% following an Outperform rating and $130 target from Evercore ISI. Both stocks have underperformed recently, with ASTS down 48% in 6 months and HOOD down 3.6% YTD.